The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine

Shahriar Behboudi

doi:10.1038/s41598-018-34760-6

The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine

Shahriar Behboudi

Bristol Veterinary School

Research output: Contribution to journal › Article (Academic Journal) › peer-review

13 Citations (Scopus)

Original language	English
Journal	Scientific Reports
DOIs	https://doi.org/10.1038/s41598-018-34760-6
Publication status	Published - Dec 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41598-018-34760-6

Handle.net

Persistent link

Cite this

@article{5da98a181bf64a9b869f984a31298cdf,

title = "The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek{\textquoteright}s disease vaccine",

author = "Shahriar Behboudi",

year = "2018",

month = dec,

doi = "10.1038/s41598-018-34760-6",

language = "English",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Research",

}

TY - JOUR

T1 - The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine

AU - Behboudi, Shahriar

PY - 2018/12

Y1 - 2018/12

UR - http://dx.doi.org/10.1038/s41598-018-34760-6

U2 - 10.1038/s41598-018-34760-6

DO - 10.1038/s41598-018-34760-6

M3 - Article (Academic Journal)

C2 - 30401976

SN - 2045-2322

JO - Scientific Reports

JF - Scientific Reports

ER -

The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine

UN SDGs

Access to Document

Handle.net

Other files and links

Cite this